Angiosoma Stock EBITDA
| GSTC Stock | USD 0.0009 0.0001 12.50% |
AngioSoma fundamentals help investors to digest information that contributes to AngioSoma's financial success or failures. It also enables traders to predict the movement of AngioSoma Pink Sheet. The fundamental analysis module provides a way to measure AngioSoma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AngioSoma pink sheet.
AngioSoma |
AngioSoma Company EBITDA Analysis
AngioSoma's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current AngioSoma EBITDA | (1.21 M) |
Most of AngioSoma's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AngioSoma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, AngioSoma reported earnings before interest,tax, depreciation and amortization of (1.21 Million). This is 100.14% lower than that of the sector and 101.21% lower than that of the EBITDA industry. The ebitda for all United States stocks is 100.03% higher than that of the company.
AngioSoma EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AngioSoma's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of AngioSoma could also be used in its relative valuation, which is a method of valuing AngioSoma by comparing valuation metrics of similar companies.AngioSoma is currently under evaluation in ebitda category among related companies.
AngioSoma Fundamentals
| Return On Asset | -44.28 | |||
| Current Valuation | 9.39 M | |||
| Shares Outstanding | 770.36 M | |||
| Shares Owned By Insiders | 10.02 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Sales | 78,201 X | |||
| Gross Profit | (2.41 K) | |||
| EBITDA | (1.21 M) | |||
| Net Income | (1.49 M) | |||
| Cash And Equivalents | 12 | |||
| Total Debt | 20 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (327 K) | |||
| Earnings Per Share | (0.02) X | |||
| Price To Earnings To Growth | (0.08) X | |||
| Beta | 1.17 | |||
| Market Capitalization | 8.47 M | |||
| Total Asset | 9 | |||
| Net Asset | 9 |
About AngioSoma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AngioSoma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AngioSoma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AngioSoma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in AngioSoma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for AngioSoma Pink Sheet analysis
When running AngioSoma's price analysis, check to measure AngioSoma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioSoma is operating at the current time. Most of AngioSoma's value examination focuses on studying past and present price action to predict the probability of AngioSoma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioSoma's price. Additionally, you may evaluate how the addition of AngioSoma to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |